Ethanolic extract of polish propolis: Chemical composition and TRAIL-R2 death receptor targeting apoptotic activity against prostate cancer cells

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Szliszka, Ewelina ^a   Sokół ŁȨtowska, Anna ^b   Kucharska, Alicja Z ^b   Jaworska, Dagmara ^a   Czuba, Zenon P ^a   Król, Wojciech ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b WROC AW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; CAFFEIC ACID; CHRYSIN; DEATH RECEPTOR 5; FERULIC ACID; LACTATE DEHYDROGENASE; LIPOCORTIN 5; METHOXYFLAVANONE; PARA COUMARIC ACID; PHENOL DERIVATIVE; PINOBANKSINE; POLISH PROPOLIS ETHANOLIC EXTRACT; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BEE EXTRACT; CANCER CELL CULTURE; CANCER PREVENTION; CELL STRAIN LNCAP; CHEMICAL COMPOSITION; DIODE ARRAY DETECTOR; DOSE TIME EFFECT RELATION; DRUG CYTOTOXICITY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; PRIORITY JOURNAL; PROSTATE CANCER; QUADRUPOLE MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; UPREGULATION;

EID: 84890065947     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/757628     Document Type: Article

References (50)

1. Kennedy D. A., Hart J., Seely D., Cost effectiveness of natural health products: a systematic review of randomized clinical trials. Evidence-Based Complementary and Alternative Medicine 2009 6 3 297 304 2-s2.0-68949105733 10.1093/ecam/nem167
2. Gibellini L., Pinti M., Nasi M., Montagna J. P., de Biasi S., Roat E., Bertoncelli L., Cooper E. L., Cossarizza A., Quercetin and cancer chemoprevention. Evidence-Based Complementary and Alternative Medicine 2011 2011 15 2-s2.0-79959266277 10.1093/ecam/neq053 591356
3. Klempner S. J., Bubley G., Complementary and alternative medicines in prostate cancer: from bench to bedside. The Oncologist 2012 17 6 830 837 10.1634/theoncologist.2012-0094
4. Szliszka E., Krol W., Soy isoflavones augment the effect of TRAIL-mediated apoptotic death in prostate cancer cells. Oncology Reports 2011 26 3 533 541 2-s2.0-79959998729 10.3892/or.2011.1332
5. Cimino S., Sortino G., Favilla V., Castelli T., Madonia M., Sansalone S., Russo G. I., Morgia G., Polyphenols: key issues involved in chemoprevention of prostate cancer. Oxidative Medicine and Cellular Longevity 2012 2012 8 632959 10.1155/2012/632959
6. Teixeira E. W., Message D., Negri G., Salatino A., Stringheta P. C., Seasonal variation, chemical composition and antioxidant activity of brazilian propolis samples. Evidence-Based Complementary and Alternative Medicine 2010 7 3 307 315 2-s2.0-77953859590 10.1093/ecam/nem177
7. Franchi G. C., Moraes C. S., Toreti V. C., Daugsch A., Nowill A. E., Park Y. K., Comparison of effects of the ethanolic extracts of brazilian propolis on human leukemic cells as assessed with the MTT assay. Evidence-Based Complementary and Alternative Medicine 2012 2012 6 2-s2.0-81555217952 10.1155/2012/918956 918956
8. Maciejewicz W., Daniewski M., Bal K., Markowski W., GC-MS identification of the flavonoid aglycones isolated from propolis. Chromatographia 2001 53 5-6 343 346 2-s2.0-0035082170 (Pubitemid 32245273)
9. Szliszka E., Czuba Z. P., Bronikowska J., Mertas A., Paradysz A., Krol W., Ethanolic extract of propolis augments TRAIL-induced apoptotic death in prostate cancer cells. Evidence-Based Complementary and Alternative Medicine 2011 2011 11 2-s2.0-80052761336 10.1093/ecam/nep180 535172
10. Kȩdzia B., Chemical composition of Polish propolis: the initial period of investigations. Postȩpy Fitoterapii 2009 1 39 44
11. Kȩdzia B., Chemical composition of Polish propolis: new studies. Postȩpy Fitoterapii 2009 2 122 128
12. Oršolić N., Šaranović A. B., Bašić I., Direct and indirect mechanism(s) of antitumour activity of propolis and its polyphenolic compounds. Planta Medica 2006 72 1 20 27 2-s2.0-32644434209 10.1055/s-2005-873167 (Pubitemid 43241587)
13. Sawicka D., Car H., Borawska M. H., Nikliński J., The anticancer activity of propolis. Folia Histochemica et Cytobiologica 2012 50 1 25 37 2-s2.0-84860307404 10.5603/FHC.2012.0004
14. Li H., Kapur A., Yang J. X., Srivastava S., McLeod D. G., Paredes-Guzman J. F., Daugsch A., Park Y. K., Rhim J. S., Antiproliferation of human prostate cancer cells by ethanolic extracts of Brazilian propolis and its botanical origin. International Journal of Oncology 2007 31 3 601 606 2-s2.0-38449122986
15. Ashkenazi A., Pai R. C., Fong S., Leung S., Lawrence D. A., Marsters S. A., Blackie C., Chang L., McMurtrey A. E., Hebert A., DeForge L., Koumenis I. L., Lewis D., Harris L., Bussiere J., Koeppen H., Shahrokh Z., Schwall R. H., Safety and antitumor activity of recombinant soluble Apo2 ligand. Journal of Clinical Investigation 1999 104 2 155 162 2-s2.0-0032713075
16. Almasan A., Ashkenazi A., Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine and Growth Factor Reviews 2003 14 3-4 337 348 2-s2.0-0038320035 10.1016/S1359-6101(03)00029-7 (Pubitemid 36693152)
17. Lee J. Y., Huerta-Yepez S., Vega M., Baritaki S., Spandidos D. A., Bonavida B., The NO TRAIL to YES TRAIL in cancer therapy (review). International Journal of Oncology 2007 31 4 685 691 2-s2.0-35848950227
18. Bronikowska J., Szliszka E., Jaworska D., Czuba Z. P., Krol W., The coumarin psoralidin enhances anticancer effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Molecules 2012 17 6 6449 6464 10.3390/molecules17066449
19. Holoch P. A., Griffith T. S., TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies. European Journal of Pharmacology 2009 625 1-3 63 72 2-s2.0-71749102407 10.1016/j.ejphar.2009.06.066
20. Pan G., O'Rourke K., Chinnaiyan A. M., Gentz R., Ebner R., Ni J., Dixit V. M., The receptor for the cytotoxic ligand TRAIL. Science 1997 276 5309 111 113 2-s2.0-0030996297 10.1126/science.276.5309.111 (Pubitemid 27161256)
21. Szliszka E., Mazur B., Zdowicz G., Czuba Z. P., Król W., TRAIL-induced apoptosis and expression of death receptor TRAIL-R1 and TRAIL-R2 in bladder cancer cells. Folia Histochemica et Cytobiologica 2009 47 4 579 585 2-s2.0-77954413094 10.2478/v10042-009-0111-2
22. Marsters S. A., Pitti R. A., Sheridan J. P., Ashkenazi A., Control of apoptosis signaling by Apo2 ligand. Recent Progress in Hormone Research 1999 54 225 234 2-s2.0-0033382845 (Pubitemid 30074693)
23. Abdulghani J., El-Deiry W. S., TRAIL receptor signaling and therapeutics. Expert Opinion on Therapeutic Targets 2010 14 10 1091 1108 2-s2.0-77957045066 10.1517/14728222.2010.519701
24. Wang S., El-Deiry W. S., TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 2003 22 53 8628 8633 2-s2.0-0346792725 10.1038/sj.onc.1207232 (Pubitemid 38019198)
25. Mellier G., Huang S., Shenoy K., Pervaiz S., TRAILing death in cancer. Molecular Aspects of Medicine 2010 31 1 93 112 2-s2.0-77649190268 10.1016/j.mam.2009.12.002
26. Zhang L., Fang B., Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Therapy 2005 12 3 228 237 2-s2.0-14644437742 10.1038/sj.cgt.7700792 (Pubitemid 40315182)
27. Thorburn A., Behbakht K., Ford H., TRAIL receptor-targeted therapeutics: resistance mechanisms and strategies to avoid them. Drug Resistance Updates 2008 11 1-2 17 24 2-s2.0-42749092258 10.1016/j.drup.2008.02.001
28. Bernardi S., Secchiero P., Zauli G., State of art and recent developments of anti-cancer strategies based on TRAIL. Recent Patents on Anti-Cancer Drug Discovery 2012 7 2 207 217 2-s2.0-84860289378 10.2174/157489212799972927
29. Szliszka E., Krol W., Polyphenols isolated from propolis augment TRAIL-induced apoptosis in cancer cells. Evidence-Based Complementary and Alternative Medicine 2013 2013 10 731940 10.1155/2013/731940
30. Szliszka E., Zydowicz G., Janoszka B., Dobosz C., Kowalczyk-Ziomek G., Krol W., Ethanolic extract of Brazilian green propolis sensitizes prostate cancer cells to TRAIL-induced apoptosis. International Journal of Oncology 2011 38 4 941 953 2-s2.0-79952350326 10.3892/ijo.2011.930
31. Walczak H., Degli-Esposti M. A., Johnson R. S., Smolak P. J., Waugh J. Y., Boiani N., Timour M. S., Gerhart M. J., Schooley K. A., Smith C. A., Goodwin R. G., Rauch C. T., TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO Journal 1997 16 17 5386 5397 2-s2.0-0030880548 10.1093/emboj/16.17.5386 (Pubitemid 27380146)
32. Bodmer J., Holler N., Reynard S., Vinciguerra P., Schneider P., Juo P., Blenis J., Tschopp J., TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nature Cell Biology 2000 2 4 241 243 2-s2.0-0033790715 10.1038/35008667
33. Falcao S. I., Vale N., Gomes P., Domingues M. R., Freire C., Cardoso S. M., Vilas-Boas M., Phenolic profiling of Portuguese propolis by LC-MS spectrometry: uncommon propolis rich in flavonoid glycosides. Phytochemical Analysis 2013 24 4 309 318 10.1002/pca.2412
34. Wojnicz D., Kucharska A. Z., Sokół-Łȩtowska A., Kicia M., Tichaczek-Goska D., Medicinal plants extracts affect virulence factors expression and biofilm formation by the uropathogenic Escherichia coli. Urological Research 2012 40 6 683 697 10.1007/s00240-012-0499-6
35. Szliszka E., Bronikowska J., Majcher A., Miszkiewicz J., Krol W., Enhanced sensitivity of hormone-refractory prostate cancer cells to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated cytotoxicity by taxanes. Central European Journal of Urology 2009 62 1 29 34 2-s2.0-75349090454
36. Szliszka E., Czuba Z. P., Sdek L., Paradysz A., Król W., Enhanced TRAIL-mediated apoptosis in prostate cancer cells by the bioactive compounds neobavaisoflavone and psoralidin isolated from Psoralea corylifolia. Pharmacological Reports 2011 63 1 139 148 2-s2.0-79953167561
37. Szliszka E., Gebka J., Bronikowska J., Krol W., Dietary flavones enhance the effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) on bladder cancer cells. Central European Journal of Urology 2010 63 3 138 143 2-s2.0-79960659256
38. Szliszka E., Czuba Z. P., Kawczyk-Krupka A., Sieron-Stoltny K., Sieron A., Krol W., Chlorin-based photodynamic therapy enhances the effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in bladder cancer cells. Medical Science Monitor 2012 18 1 BR47 BR53 2-s2.0-84855280821
39. Szliszka E., Helewski K. J., Mizgala E., Krol W., The dietary flavonol fisetin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells. International Journal of Oncology 2011 39 4 771 779 2-s2.0-79960868417 10.3892/ijo.2011.1116
40. Szliszka E., Czuba Z. P., Mertas A., Paradysz A., Krol W., The dietary isoflavone biochanin-a sensitizes prostate cancer cells to TRAIL-induced apoptosis. Urologic Oncology: Seminars and Original Investigations 2013 31 3 331 342 2-s2.0-79960654585 10.1016/j.urolonc.2011.01.019
41. Chernetsova E. S., Bromirski M., Scheibner O., Morlock G. E., DART-Orbitrap MS: a novel mass spectrometric approach for the identification of phenolic compounds in propolis. Analytical and Bioanalytical Chemistry 2012 403 10 2859 2867 2-s2.0-84857131130 10.1007/s00216-012-5800-6
42. Keckes S., Gasic U., Cirkovic-Velickovic T., Milojkovic-Opsenica D., Natic M., Tesic Z., The determination of phenolic profiles of Serbian unifloral honeys using ultra-high-performance liquid chromatography/high resolution accurate mass spectrometry. Food Chemistry 2013 138 1 32 40 10.1016/j.foodchem. 2012.10.025
43. Ding J., Polier G., Köhler R., Giaisi M., Krammer P. H., Li-Weber M., Wogonin and related natural flavones overcome tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein resistance of tumors by down-regulation of c-FLIP protein and up-regulation of TRAIL receptor 2 expression. The Journal of Biological Chemistry 2012 287 1 641 649 2-s2.0-84855292731 10.1074/jbc.M111.286526
44. Horinaka M., Yoshida T., Shiraishi T., Nakata S., Wakada M., Sakai T., The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand. Molecular Cancer Therapeutics 2006 5 4 945 951 2-s2.0-33646574281 10.1158/1535-7163.MCT-05-0431 (Pubitemid 43724594)
45. Chen W., Wang X., Zhuang J., Zhang L., Lin Y., Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells. Carcinogenesis 2007 28 10 2114 2121 2-s2.0-35148854568 10.1093/carcin/bgm133 (Pubitemid 47543370)
46. Psahoulia F. H., Drosopoulos K. G., Doubravska L., Andera L., Pintzas A., Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts. Molecular Cancer Therapeutics 2007 6 9 2591 2599 2-s2.0-34748906001 10.1158/1535-7163.MCT-07-0001 (Pubitemid 47480425)
47. Kim J. Y., Kim E. H., Park S. S., Lim J. H., Kwon T. K., Choi K. S., Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation. Journal of Cellular Biochemistry 2008 105 6 1386 1398 2-s2.0-57349169369 10.1002/jcb.21958
48. Jung Y. H., Heo J., Lee Y. J., Kwon T. K., Kim Y. H., Quercetin enhances TRAIL-induced apoptosis in prostate cancer cells via increased protein stability of death receptor 5. Life Sciences 2010 86 9-10 351 357 2-s2.0-76849117108 10.1016/j.lfs.2010.01.008
49. Yoshida T., Konishi M., Horinaka M., Yasuda T., Goda A. E., Taniguchi H., Yano K., Wakada M., Sakai T., Kaempferol sensitizes colon cancer cells to TRAIL-induced apoptosis. Biochemical and Biophysical Research Communications 2008 375 1 129 133 2-s2.0-50149121804 10.1016/j.bbrc.2008.07.131
50. Szliszka E., Zydowicz G., Mizgala E., Krol W., Artepillin C, (3,5-diprenyl-4-hydroxycinnamic acid) sensitizes prostate cancer LNCaP cells to TRAIL-induced apoptosis. International Journal of Oncology 2012 41 818 828